Cite

HARVARD Citation

    Rainer, Q. et al. (n.d.). 9 Safety of Human Chorionic Gonadotropin Monotherapy for Men with Hypogonadal Symptoms and Testosterone >300 ng/dL. Journal of sexual medicine. 19 (1), p. S5. [Online]. 
  
Back to record